Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04275596
Other study ID # Mansoura 123
Secondary ID
Status Recruiting
Phase Phase 3
First received
Last updated
Start date February 10, 2020
Est. completion date May 30, 2021

Study information

Verified date February 2020
Source Mansoura University
Contact Sameh H Emile, M.D.
Phone +201006267150
Email sameh200@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

2QR-complex is a patented molecule extracted from Aloe vera barbadensis leaves that blocks the adhesion of pathogenic microbes to human epithelial cells and tissues [9]. Anti-adhesion therapy such as 2QR-complex has been suggested as an alternative to antibiotics in the treatment of bacterial infections. 2QR-complex based products have already shown comparable efficacy to antibiotics in treating mucosal infections such as bacterial vaginosis.

In the present study we aim to assess the efficacy of 2QR-complex in pain relief and promotion of anal wound healing after anal surgery. We presumed that anal discomfort and prolonged healing after surgery for anal fissure, fistula, and hemorrhoids may in part be due to contamination of the wound with fecal bacteria that colonize at the surgical site. Therefore, we assumed that the use of topical anti-adhesive 2QR-complex-based product may serve to minimize this negative impact on wound healing.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date May 30, 2021
Est. primary completion date March 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Adult patients of either sex with simple anal fistula, chronic anal fissure, or grade III/IV hemorrhoids will be included.

Exclusion Criteria:

- Patients with other anal conditions, diabetic patients, patients under steroid or immunosuppressive therapy will be excluded.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
2QR complex
Application of topical gel containing 2QR complex on the anal wound until complete wound healing
Placebo
Application of topical placebo on the anal wound until complete wound healing

Locations

Country Name City State
Egypt Mansoura university hospital Mansourah Dakahlia

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to complete anal Wound healing The time required to achieve complete Complete epithelization of the anal wound postoperatively Six weeks after surgery
Secondary Anal pain pain assessed using visual analogue scale from 0-10 one week, one month, two months after surgery